Suppr超能文献

Wb5,一种用于监测班氏吴策线虫消除大规模药物管理项目疗效和成功与否的新型生物标志物。

Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination.

作者信息

Pietrow Rachel E, Bjerum Catherine, Koudou Benjamin G, Supali Taniawati, Budge Philip J, Fischer Peter U, Nutman Thomas B, Bennuru Sasisekhar

机构信息

Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.

出版信息

PLoS Negl Trop Dis. 2025 May 30;19(5):e0013146. doi: 10.1371/journal.pntd.0013146. eCollection 2025 May.

Abstract

The success of mass drug administration at reducing the prevalence of lymphatic filariasis in endemic areas has led to an increased need for highly sensitive and specific diagnostic assays. To be useful in post-elimination surveillance in areas with low to zero prevalence, high test performance characteristics are required to enable the early detection of infection recrudescence. As current testing suffers from either sensitivity or specificity levels that fail to meet adopted target product profiles, additional targets that could be used as confirmatory tests or in multiplexed assays could overcome these issues. To this end, bioinformatic analyses coupled with stage-specific expression data for W. bancrofti (Wb) and/or B. malayi (Bm) resulted in the identification of 12 targets that were: 1) present in Wb and/or Bm; 2) had very little to no homology with proteins from other filariae; and 3) were enriched in the microfilarial or L3 stages. Screening of these 12 antigens by a Luciferase Immunoprecipitation System assay for IgG with serum from Wb-infected and uninfected individuals identified a single antigen, termed Wb5, that was specific for Wb infections only. Recombinant Wb5 proteins were generated in multiple expression systems for use in a variety of IgG4-based immunoassays. To assess if Wb5 could provide additional sensitivity to assays using IgG4 antibodies to Wb123, head-to-head comparisons were performed using serum from 466 samples (231 Wb-infected, 235 controls). Using IgG4-based immunoassays at 100% specificity against uninfected controls and other helminth species (O. volvulus, L. loa, S. stercoralis, M. perstans), Wb5 and Wb123 had individual sensitivities of 53.7% and 75.3%, respectively, while a combination resulted in 81.0% sensitivity. Moreover, kinetic studies of patients that were treated and followed up longitudinally suggest that Wb5 titers may decline more sharply than those of Wb123, thus paving the way for Wb5 as a complementary tool to Wb123.

摘要

群体药物给药在降低流行地区淋巴丝虫病患病率方面的成功,导致对高灵敏度和特异性诊断检测方法的需求增加。为了在患病率低至零的地区进行消除后监测时发挥作用,需要高检测性能特征以实现感染复发的早期检测。由于目前的检测在灵敏度或特异性水平上未能达到采用的目标产品概况,可用作确证试验或多重检测的其他靶标可以克服这些问题。为此,结合班氏吴策线虫(Wb)和/或马来布鲁线虫(Bm)的阶段特异性表达数据进行生物信息学分析,鉴定出12个靶标,这些靶标:1)存在于Wb和/或Bm中;2)与其他丝虫的蛋白质几乎没有同源性;3)在微丝蚴或L3阶段富集。通过荧光素酶免疫沉淀系统检测针对Wb感染和未感染个体血清中的IgG对这12种抗原进行筛选,鉴定出一种仅对Wb感染具有特异性的单一抗原,称为Wb5。在多种表达系统中产生重组Wb5蛋白,用于各种基于IgG4的免疫测定。为了评估Wb5是否可以为使用针对Wb123的IgG4抗体的检测提供额外的灵敏度,使用来自466个样本(231个Wb感染,235个对照)的血清进行了直接比较。使用针对未感染对照和其他蠕虫物种(旋盘尾丝虫、罗阿丝虫、粪类圆线虫、常现曼森线虫)具有100%特异性的基于IgG4的免疫测定,Wb5和Wb123的个体灵敏度分别为53.7%和75.3%,而两者组合的灵敏度为81.0%。此外,对接受治疗并进行纵向随访的患者的动力学研究表明,Wb5滴度可能比Wb123滴度下降得更急剧,从而为Wb5作为Wb123的补充工具铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee6c/12165424/e8fcdea9d4cf/pntd.0013146.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验